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Differentiation of 3T3-Ll cells from fibroblasts to adipocytes is accompanied by increased adenylate cyclase 
response to lipolytic agents. We used pertussis toxin and specific antibodies to measure the inhibitory gua- 
nine nucleotide-binding protein, G,, and the novel G-protein, G,, in membranes from 3T3-Ll cells. Pertussis 
toxin-dependent labeling of a 39-40 kDa protein showed an initial 30% rise, followed by an 80% fall during 
differentiation. Immunoblots showed that 3T3-Ll cells contain G,, as well as G,, and that changes in the 
former parallel the changes in pertussis toxin labeling. Changes in G, and G, may contribute to altered aden- 
ylate cyclase response during 3T3-L 1 cell differentiation. 
Pertussis toxin Adenylate cyclase Signal transduction 
1. INTRODUCTION 
3T3-Ll fibroblasts differentiate either spon- 
taneously [l] or after treatment with agents such as 
DEX f IBMX into adipocytes [2]. Differentiation 
of 3T3-Ll cells from fibroblasts to adipocytes is 
accompanied by increased responsiveness of 
adenylate cyclase to lipolytic agents [ 11. Previous 
studies [2,3] indicate that changes in hormone 
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Abbreviations: G-protein, guanine nucleotide-binding 
protein; G, and Gi, the G-proteins associated with 
stimulation and inhibition, respectively, of adenylate 
cyclase; Go, a G-protein of unknown function 
discovered in brain; DEX + IBMX, dexa- 
methasone + isobutylmethylxanthine 
receptors or in G, cannot by themselves account 
for increased cyclase response. Since adenylate 
cyclase is also subject to inhibitory regulation by a 
distinct Gi protein [4], we attempted to measure Gi 
in membranes from differentiating cells. Pertussis 
toxin-catalyzed ADP-ribosylation, which has been 
used as a specific probe for Gi [5], is now known 
to ADP-ribosylate other G-proteins, including G,, 
a novel G-protein of unknown function, first 
purified from brain [6-81. Therefore, we used 
specific antibodies against Gi [9] and G, [lo], in 
addition to pertussis toxin labeling, to measure 
these proteins in 3T3-Ll cells. 
2. EXPERIMENTAL 
3T3-Ll and 3T3-C2 cells were cultured as 
described [2]; confluent cells (day 0) were treated 
for 48 h with fresh medium containing 0.25 pM 
dexamethasone and 0.5 mM isobutylmethylxan- 
thine (DEX + IBMX); after 48 h (day 2), cells were 
refed with fresh medium and harvested at days 4 
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and 6 after initial treatment. Cell membranes were 
prepared as in [2]. 
Gi and G, were purified from bovine brain as in 
[8]. Rabbit antisera against Gi [9] and G, [lo] were 
prepared and characterized as described. 
Adenylate cyclase was assayed as in [2]. Pertussis 
toxin radiolabeling was done as in [9]. Briefly, per- 
tussis toxin (kindly provided by Dr R. Sekura, 
NICHD) was activated by incubation for 1 h at 
room temperature in 20 mM Tris-HCl, pH 7.5, 
with 50 mM dithiothreitol. Activated toxin 
(35 fig/ml final concentration) was added to buffer 
containing 20 mM Tris-HCI, pH 8.0, 5 mM 
dithiothreitol, 2 mM ATP, and 5Opg membrane 
protein in a final volume of 0.1 ml. To this was 
added [~u-~‘P]NAD (35 &i/ml, New England 
Nuclear); final concentration 10pM NAD. The 
reaction mixture was incubated for 1 h at 37”C, 
and the reaction terminated by addition of SDS- 
PAGE sample buffer. SDS-PAGE and auto- 
radiography were performed as in [9,10]. M, 
estimates are based on standard proteins (Bethesda 
Research Labs, high-Mr) run in parallel. Immuno- 
blotting was performed as in [9,11] with affinity- 
purified antibodies [lo] and radioiodinated protein 
A (New England Nuclear). Quantitative im- 
munoblotting of the common &subunit was per- 
formed as in [9,10] with purified transducin P/y- 
subunit as standard. 
3. RESULTS 
We compared 3T3-Ll cells treated with 
DEX + IBMX to another fibroblast cell line, 
3T3-C2, similarly treated. As noted in [2], by day 
6 approx. 90% of 3T3-Ll cells have differentiated 
into adipocytes, whereas virtually no 3T3-C2 cells 
differentiate. Pertussis toxin-dependent ADP- 
ribosylation [5] was used to measure Gi in plasma 
membranes from 3T3-Ll and 3T3-C2 cells (fig.1). 
A toxin-dependent band of approx. 39-40 kDa 
was observed on autoradiograms. Densitometric 
quantitation of this band showed a 30% rise in 
membranes from Ll cells 2 days after 
DEX + IBMX followed by a 71 and 83% fall at 
days 4 and 6, respectively (all values relative to day 
0 = 100%). In contrast, C2 cells showed very little 
change 6 days after DEX + IBMX (77 and 83% 
respectively for day 0 and day 6 3T3-C2 cells, 
relative to day 0 3T3-Ll cells). 
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Fig. 1. Pertussis toxin-dependent ADP-ribosylation of an 
approx. 40 kDa protein in membranes derived from 
3T3-Ll and 3T3-C2 cells. Membranes were prepared 
from 3T3-Ll cells before treatment with DEX + IBMX 
(day 0) and 2, 4 and 6 days after treatment, and from 
3T3-C2 cells before treatment (- DEX) and 6 days after 
treatment (+ DEX). Membranes were treated with 
[(y-32P]NAD and with or without pertussis toxin, and 
subjected to SDS-PAGE and autoradiography (see 
section 2). 25 pg membrane protein were loaded per 
lane. The band shown is the only one labeled in a 
pertussis toxin-dependent manner and is denoted as 
Gr/G,e based on the immunoblot results in fig.2. 
We next used affinity-purified antibodies 
specific for either Gi [9] or G, [lo] to determine 
whether the latter is present in 3T3-Ll cells, and to 
measure changes during differentiation. Both 
types of antibodies also react with the common 
(approx. 35 kDa) P-subunit of G-proteins [9-l 11. 
Antiserum RV3 has been shown to react specifical- 
ly with Go*, and not with Gi, G,, or transducin-cu 
[lo]. In contrast, antiserum CW6 was raised 
against transducin but cross-reacts strongly with 
Gi+, and weakly, if at all, with G,-cw [9]. Fig.2A 
shows the specificity of the antisera used on im- 
munoblot strips containing a mixture of Gj and G,. 
Both antisera react with the common P-subunit 
(although to a different degree). The selectivity of 
CW6 for Gie (fig.2A, lane 2) and of RV3 for Go- 
(lane 3) is reflected in the greater distance on im- 
munoblot between LY- and P-bands for CW6 com- 
pared with RV3 (as expected if CW6 reacts with 
the higher Gr-a-band). Previous experiments in 
which immunoblots of Gi and G, performed with 
a mixture of CW6 and RV3 revealed the resolved 
Gr- and Go* doublet provide definitive evidence 
for the selectivity of these antisera [lo]. 
Immunoblots with CW6 and RV3 (fig.2B,C) 
show that both Gi+ and G,-cr decrease substantial- 
ly by day 6 in 3T3-Ll cells (by 64 and 80%) respec- 
tively, compared with day 0 cells). At day 2, Gr-a 
was relatively unchanged (7% reduction) but G,,_(y 










Fig.2. Immunoblots of purified G, and G, (A) and of 
3T3-Ll and 3T3-C2 cell membranes (B,C) with affinity- 
purified antibodies specific for Gi and G,. (A) Gr and G, 
purified from bovine cerebral cortex were subjected to 
SDS-PAGE and either stained with Coomassie blue 
(lane 1,4 pg), or immunoblotted with antibodies specific 
for Gia andfl (lane 2, 1.5 ag) or with antibodies specific 
for G,,-cu and p (lane 3, 0.8 pg). In B and C, plasma 
membranes prepared from 3T3-Ll and 3T3-C2 cells 
treated with DEX + IBMX (as in fig.1 legend) were 
subjected to SDS-PAGE (150 @g/lane) and immuno- 
blotting with antibodies specific for Gi (B) or Go (C). 
The arrows indicate the a-subunits of Gi and G, and the 
common&subunit. The identity of the protein above G,- 
(Y that reacts with Gi-specific antibodies is unknown (B). 
No other bands were stained on the immunoblots. 
increased by 48% compared with day 0 3T3-Ll 
cells. Neither Gi nor G,_(y declined by day 6 in 
3T3-C2 cells. For the experiment shown, both 
subunits actually increased by day 6 after 
DEX + IBMX but this was exceptional, and in 
most experiments (cf. fig. 1) no difference between 
UC~Y u and day 6 3T3-C2 cells was observed. In con- 
trast, 3T3-Ll cells reproducibly (at least 2 separate 
experiments on 3 independently differentiated sets 
of cells) showed a marked decline in Gi and G, by 
day 6, and a rise in G, at day 2. 
The common P-subunit also decreases in mem- 
branes of differentiated 3T3-Ll cells (fig.2). In 
separate quantitative immunoblots using purified 
transducin /3/y-subunit as standard, we deter- 
mined that there is approx. 1.4pg fl/mg total 
membrane protein in day 0 3T3-Ll cells, and that 
p decreases by 21, 74 and 83% at days 2, 4 and 6, 
respectively. Again, no decline was seen in 3T3-C2 
cell membranes treated with DEX + IBMX. 
Since 3T3-Ll cells increase in size during dif- 
ferentiation, the yield of membrane protein/cell 
increases (by a factor of 2.7) from day 0 to day 6 
[2]. In figs 1 and 2, equal amounts of membrane 
protein are compared. If the data are normalized 
for cell number there is a 50% decrease in @ 
subunits and in Go*, but no change in Gi+ from 
day 0 to day 6 in 3T3-Ll cells. 
In agreement with [2], adenylate cyclase activity 
in membranes from the cells shown in figs 1 and 2 
shows two major changes during differentiation: 
(i) increased response to the &adrenergic agonist, 
isoproterenol, in day 6 compared with day 0 
3T3-Ll but not 3T3-C2 cells; (ii) lowest absolute 
activity in response to all stimulators 
(isoproterenol or guanine nucleotides) at day 2 (not 
shown). 
4. DISCUSSION 
Adenylate cyclase activity is regulated by both 
stimulatory and inhibitory G proteins (41. 
Although differentiation of 3T3-Ll cells is accom- 
panied by increased Gs (measured by cholera toxin 
radiolabeling) this change alone is unlikely to ex- 
plain increased adenylate cyclase response, since a 
similar rise in G, was observed in 3T3-C2 cells 
treated with DEX + IBMX (31. 3T3-C2 cells, 
however, do not differentiate to adipocytes in 
response to DEX + IBMX, nor do they show in- 
creased adenylate cyclase response after treatment 
WI. 
Our data suggest hat changes in inhibitory G- 
proteins may contribute to altered adenylate 
cyclase activity during 3T3-Ll cell differentiation. 
The mechanism of inhibition of adenylate cyclase 
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by Gi is unclear. Although Gi+ appears capable of 
inhibition under certain conditions [12], most 
evidence points to a predominant role for the P/y- 
subunit [ 131. The function of G, is unknown (see 
below) but since it appears to contain the common 
P/y-subunit, G, may also play a role in adenylate 
cyclase inhibition [6]. Thus, the increase in G, at 
day 2 (and an increase in &subunit when expressed 
per cell number) may be relevant to the decline in 
absolute adenylate cyclase activity at day 2. The 
decline in both Gi and G, by day 6 in 3T3-Ll but 
not 3T3-C2 cells may also help explain the increase 
in agonist-stimulated activity at day 6 in Ll but not 
C2 cells. Additional factors, such as a concomitant 
increase in G, [2,3], or changes in other regulatory 
factors could also be involved. 
Our data on G, provide clearcut evidence for the 
occurrence of this novel G-protein in a non-neural 
cell. Previous reports of two pertussis toxin 
substrates in fat cells [14,15] left unclear the 
specific identity of these proteins. Identification of 
G, in tissues other than brain, e.g. heart [6,16], 
also did not indicate the specific Go-containing cell 
type. If one can extrapolate from 3T3-Ll cells, our 
data suggest that normal fibroblasts and 
adipocytes may contain G,. 
Although the specific function of G, is 
unknown, its location in the plasma membrane 
and heterotrimeric structure, analogous to that of 
other G-proteins [4], suggest a role in signal 
transduction. The rise in G, observed in 3T3-Ll 
cells at day 2 after DEX + IBMX and subsequent 
decline with differentiation are of interest with 
respect to the possible function of G,. Treatment 
of 3T3-Ll cells with DEX + IBMX is followed in- 
itially by cell proliferation which is completed by 
day 2 when DEX + IBMX are removed from the 
medium [ 171. Differentiation follows thereafter. 
This leads us to speculate that G, could be involved 
in a signal transduction pathway related to control 
of cell division. The relatively high concentrations 
of G, (approx. 1% of total membrane protein) in 
fully differentiated, non-dividing neural cells 
[6,10] would appear to argue against a role for G, 
in control of cell proliferation, but it should be 
noted that other proteins ordinarily associated 
with cell proliferation such as the product of the 
SK proto-oncogene are also abundant in neural 
cells [18]. Cultured 3T3-Ll cells should prove 
useful in helping elucidate the function of G,, and 
as a, model system for studying alterations in G- 
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